Had the now-scrapped changes to FoI laws been in place in recent years, it is likely that the previously unlawful arrangements for the Opiate Dependence Treatment Program and the employment workaround that led a health department official to secretly release confidential company pricing information, leading to its publication in the infamous 'Vancouver' poster, would never have been exposed.
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 Latest NewsBioPharmaComment
Latest Video
New Stories
-
US launches investigation into pharmaceutical pricing with potential broad implications
June 23, 2026 - - Latest News -
Access delays in cancer medicines are costing Australia productivity, livelihoods, and lives
June 23, 2026 - - Latest News -
If we're incapable of delivering meaningful change, we should hope the US intervenes
June 23, 2026 - - Latest News -
'AUScelerate' emerges as new name for MTPConnect ahead of BIO 2026
June 22, 2026 - - Australian Biotech -
CSL executive Elizabeth Rex joins AusBiotech board as observer
June 22, 2026 - - Latest News -
It seems that one critical stakeholder group is missing in this website design
June 22, 2026 - - Latest News -
May 2026 delivers paediatric dosing flexibility, vaccine decisions, and policy updates
June 22, 2026 - - Latest News


